Загрузка...
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
BACKGROUND: Modern guidelines recommend sodium-glucose cotransporter-2 (SGLT2) inhibitors as the preferred antihyperglycemic agents for patients with type 2 diabetes and chronic kidney disease. However, the mechanisms underlying the renal protective effect of SGLT2 inhibitors are not fully understoo...
Сохранить в:
| Опубликовано в: : | World J Diabetes |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754166/ https://ncbi.nlm.nih.gov/pubmed/33384767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v11.i12.596 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|